M...do you think perhaps a big pharma takeover candidate is guiding ATHE and instructing them what they need to do before they will pull the trigger on a take-out or partnership deal? Over 10 years ago, I felt that Eli Lilly was a prime candidate and that still remains a possibility today, IMO, with their recent renewed interest in pursuing the Alzheimer's holy grail. Fingers crossed...
Ann: New US patent targeting major neurodegenerative diseases, page-10
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.001(11.1%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $14.25K | 2.930M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 66 | 81346070 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 19609447 | 23 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| ATH (ASX) Chart |